At GD BioPharma, we redefine drug discovery through AI-powered de novo design and a strategic differentiated portfolio, driven by a passion for transformative medicines.

Our AI-driven platform disrupts traditional drug discovery to deliver next-generation small molecules, optimizing for enhanced safety, efficacy, and global accessibility.